Related Experiment Video
Updated: Feb 22, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis
Martin Hoenigl1,2,3,4, Susanne Eigl1, Sven Heldt1
1Division of Pulmonology, Medical University of Graz, Graz, Austria.
Abstract:
The study evaluated the newly formatted Aspergillus-specific lateral-flow-device (LFD), and compared its performance to the original prototype "old" LFD test using BALF samples from 28 patients (14 patients with probable/proven invasive pulmonary aspergillosis [IPA] and 14 patients with no evidence for IPA). A total of 10/14 (71%) of BALF samples from patients with probable/proven IPA resulted positive with the new LFD, including 8/9 with true-positive and 2/5 with false-negative results with the old LFD. All 14 samples from patients without IPA resulted negative with the new LFD; specificity of the new LFD was significantly improved compared to the old LFD.
Insights
A new Aspergillus-specific lateral-flow-device (LFD) shows improved performance for diagnosing invasive pulmonary aspergillosis (IPA). The enhanced LFD test demonstrated higher specificity and sensitivity in patient samples compared to the original prototype.
Area of Science:
- Medical diagnostics
- Mycology
- Infectious diseases
Background:
- Invasive pulmonary aspergillosis (IPA) is a serious fungal infection.
- Accurate and rapid diagnostic tools for IPA are crucial for timely treatment.
- Existing diagnostic methods, including earlier lateral-flow-device (LFD) prototypes, have limitations.
Purpose of the Study:
- To evaluate the diagnostic performance of a newly formatted Aspergillus-specific LFD.
- To compare the new LFD test against the original prototype LFD.
- To assess the utility of the new LFD in bronchoalveolar lavage fluid (BALF) samples.
Main Methods:
- The study utilized BALF samples from 28 patients.
- Patients were categorized into two groups: 14 with probable/proven IPA and 14 without evidence of IPA.
- Performance metrics (sensitivity and specificity) of the new LFD were compared to the old LFD prototype.
Main Results:
- The new LFD correctly identified 10 out of 14 (71%) BALF samples from IPA patients.
- It achieved true-positive results in 8/9 cases previously false-negative with the old LFD.
- All 14 samples from non-IPA patients tested negative with the new LFD, indicating improved specificity.
Conclusions:
- The newly formatted Aspergillus-specific LFD demonstrates enhanced diagnostic accuracy for IPA.
- The improved specificity of the new LFD reduces the likelihood of false-positive results.
- This new LFD holds promise as a more reliable tool for diagnosing IPA.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...